LU74763A1 - - Google Patents

Info

Publication number
LU74763A1
LU74763A1 LU74763A LU74763A LU74763A1 LU 74763 A1 LU74763 A1 LU 74763A1 LU 74763 A LU74763 A LU 74763A LU 74763 A LU74763 A LU 74763A LU 74763 A1 LU74763 A1 LU 74763A1
Authority
LU
Luxembourg
Application number
LU74763A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU74763A1 publication Critical patent/LU74763A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
LU74763A 1975-04-18 1976-04-14 LU74763A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752517771 DE2517771A1 (de) 1975-04-18 1975-04-18 Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
LU74763A1 true LU74763A1 (cg-RX-API-DMAC7.html) 1977-01-12

Family

ID=5944669

Family Applications (1)

Application Number Title Priority Date Filing Date
LU74763A LU74763A1 (cg-RX-API-DMAC7.html) 1975-04-18 1976-04-14

Country Status (15)

Country Link
US (1) US4073934A (cg-RX-API-DMAC7.html)
JP (1) JPS51131860A (cg-RX-API-DMAC7.html)
AT (1) AT360182B (cg-RX-API-DMAC7.html)
AU (1) AU510088B2 (cg-RX-API-DMAC7.html)
BE (1) BE840872A (cg-RX-API-DMAC7.html)
CA (1) CA1079725A (cg-RX-API-DMAC7.html)
CH (1) CH626876A5 (cg-RX-API-DMAC7.html)
DE (1) DE2517771A1 (cg-RX-API-DMAC7.html)
DK (1) DK142976A (cg-RX-API-DMAC7.html)
FR (1) FR2307525A1 (cg-RX-API-DMAC7.html)
GB (1) GB1549047A (cg-RX-API-DMAC7.html)
IE (1) IE43600B1 (cg-RX-API-DMAC7.html)
LU (1) LU74763A1 (cg-RX-API-DMAC7.html)
NL (1) NL7604016A (cg-RX-API-DMAC7.html)
SE (1) SE7604409L (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2517772A1 (de) * 1975-04-18 1976-10-28 Schering Ag Cyclopentanderivate und verfahren zu ihrer herstellung
US4268522A (en) * 1976-06-14 1981-05-19 Pfizer Inc. 13,14-Dihydro-15-alkenyl- and 13,14-dihydro-15-alkynyl prostaglandins and analogs thereof
DE2729960A1 (de) * 1977-06-30 1979-01-18 Schering Ag Neue acetylenprostaglandine und verfahren zu ihrer herstellung
JPS6033429B2 (ja) * 1980-04-28 1985-08-02 小野薬品工業株式会社 プロスタグランジン類似化合物
GB2225573A (en) * 1988-09-16 1990-06-06 Ueno Seiyaku Oyo Kenkyujo Kk 13,14-dihydro-15-keto-PGFs
ID24845A (id) * 1997-09-09 2000-08-24 Procter & Gamble Prostaglandin tetrahidro tersubstitusi c16-c20 aromatik yang berguna sebagai agonis fp
CA2303764C (en) * 1997-09-09 2005-02-15 The Procter & Gamble Company Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
CA2364948C (en) * 1999-03-05 2011-04-26 Duke University C16 unsaturated fp-selective prostaglandins analogs
WO2000051977A1 (en) * 1999-03-05 2000-09-08 The Procter & Gamble Company Aldehyde intermediates for the preparation of prostaglandin derivatives
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US7461968B2 (en) * 2003-10-30 2008-12-09 Deka Products Limited Partnership System, device, and method for mixing liquids
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
EP2875022B1 (en) 2012-07-19 2016-10-12 Cayman Chemical Company, Incorporated Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
WO2014144500A2 (en) 2013-03-15 2014-09-18 Cayman Chemical Company, Inc. Methods of synthesizing a difluorolactam analog
PT2989098T (pt) 2013-03-15 2017-08-16 Cayman Chemical Co Inc Compostos de lactama como agonistas selectivos do receptor ep4 para uso no tratamento de doenças e condições mediadas por ep4
CN105392505A (zh) 2013-07-19 2016-03-09 开曼化学股份有限公司 用于促进骨生长的方法、系统和组合物
US10494338B2 (en) 2016-05-09 2019-12-03 AGC Inc. Prostaglandin derivative
CN111263750B (zh) 2017-10-31 2022-02-25 Agc株式会社 前列腺素衍生物的制造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140427A (cg-RX-API-DMAC7.html) * 1974-02-27 1975-11-11

Also Published As

Publication number Publication date
AT360182B (de) 1980-12-29
DE2517771A1 (de) 1976-10-28
GB1549047A (en) 1979-08-01
CA1079725A (en) 1980-06-17
IE43600B1 (en) 1981-04-08
DK142976A (da) 1976-10-19
ATA273976A (de) 1980-05-15
CH626876A5 (cg-RX-API-DMAC7.html) 1981-12-15
US4073934A (en) 1978-02-14
JPS51131860A (en) 1976-11-16
AU510088B2 (en) 1980-06-05
NL7604016A (nl) 1976-10-20
FR2307525B1 (cg-RX-API-DMAC7.html) 1980-11-28
AU1314876A (en) 1977-10-27
SE7604409L (sv) 1976-10-19
FR2307525A1 (fr) 1976-11-12
BE840872A (fr) 1976-10-18
IE43600L (en) 1976-10-18

Similar Documents

Publication Publication Date Title
FR2307525B1 (cg-RX-API-DMAC7.html)
FR2300557B1 (cg-RX-API-DMAC7.html)
JPS51114892U (cg-RX-API-DMAC7.html)
JPS51121554U (cg-RX-API-DMAC7.html)
JPS51134917U (cg-RX-API-DMAC7.html)
JPS556808Y2 (cg-RX-API-DMAC7.html)
FR2332562B2 (cg-RX-API-DMAC7.html)
JPS51146576U (cg-RX-API-DMAC7.html)
JPS5435926Y2 (cg-RX-API-DMAC7.html)
JPS526725Y2 (cg-RX-API-DMAC7.html)
JPS5518366B2 (cg-RX-API-DMAC7.html)
JPS542981B2 (cg-RX-API-DMAC7.html)
JPS51142537U (cg-RX-API-DMAC7.html)
JPS5194373U (cg-RX-API-DMAC7.html)
JPS5221510U (cg-RX-API-DMAC7.html)
CH608067A5 (cg-RX-API-DMAC7.html)
BG22893A1 (cg-RX-API-DMAC7.html)
CH593593A5 (cg-RX-API-DMAC7.html)
BG21435A1 (cg-RX-API-DMAC7.html)
CH596331A5 (cg-RX-API-DMAC7.html)
CH599497A5 (cg-RX-API-DMAC7.html)
CH581241A5 (cg-RX-API-DMAC7.html)
CH600713A5 (cg-RX-API-DMAC7.html)
CH602531A5 (cg-RX-API-DMAC7.html)
BG21749A1 (cg-RX-API-DMAC7.html)